Roger Paredes

机构：Instituto de Salud Carlos III, IrsiCaixa, Red de Investigación en Sida, Centro de Investigación Biomédica en Red, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, Fundació Lluita contra les Infeccions, Case Western Reserve University, Universitat Politècnica de Catalunya · ORCID：0000-0002-6553-691X

发表论文 456 篇 · 总被引 27391 次 · h-index 69

代表论文

• Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial (2025 · The Lancet Infectious Diseases · 被引 23)
• Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19 (2025 · Scientific Reports · 被引 4)
• Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial (2026 · Clinical Infectious Diseases · 被引 1)
• Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._ (2025 · Communications Medicine · 被引 1)
• Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe (2025 · JHEP Reports · 被引 1)
• Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial (2025 · Clinical Microbiology and Infection · 被引 1)